Merdury Biopharmaceutical Corporation (TPEX:6932)
5.10
-0.25 (-4.67%)
Sep 8, 2026, 1:40 PM CST
| Market Cap | 2.42B -27.3% |
| Revenue (ttm) | n/a |
| Net Income | -51.62M |
| EPS | -0.12 |
| Shares Out | 427.65M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 244,064 |
| Open | 5.35 |
| Previous Close | 5.35 |
| Day's Range | 5.05 - 5.36 |
| 52-Week Range | 4.71 - 12.20 |
| Beta | -1.11 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 13, 2026 |